Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Chromoendoscopy for GI Tumor Neurogenesis
NCT05232357Phase 1Unknown
- Sponsor
- Academy of Military Medical Sciences
- Start
- Mar 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of methylene blue in gastrointestinal neoplasms, gastritis and Intestinal polyps, sponsored by Academy of Military Medical Sciences. Primary endpoints: Morphological characteristics of mucosal nerves and Expression levels of PGP9.5, GFAP, VIP, nNOS, TH, ChAT and SOM. Status: unknown.
02
Drugs
methylene blue
03
Conditions
gastrointestinal neoplasmsgastritisIntestinal polyps
Beyond the preview
Go deeper on NCT05232357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05232357.